Exploring the anti-cancer potential of SGLT2 inhibitors in breast cancer treatment in pre-clinical and clinical studies
Yasaman Naeimzadeh, Amir Tajbakhsh, Mahnaz Nemati, Jafar Fallahi
Topics & Concepts
CanagliflozinEmpagliflozinDapagliflozinPI3K/AKT/mTOR pathwayMedicineAMPKBreast cancerCancerPharmacologyContext (archaeology)Cancer researchTriple-negative breast cancerBioinformaticsSignal transductionKinaseType 2 Diabetes MellitusBiologyProtein kinase AInternal medicineDiabetes mellitusEndocrinologyBiochemistryCell biologyPaleontologyMetabolism, Diabetes, and CancerDiabetes Treatment and ManagementAdvanced Breast Cancer Therapies